Advances in anxiety management.
Recent developments in neurobiology, diagnostic classification, and drug/psychotherapy trials have increased our ability to manage patients with anxiety disorders. These recent developments, along with epidemiologic surveys showing the high frequency of anxiety disorders in the general population as well as in the primary care population, have reemphasized the importance of anxiety disorders in family practice. This review presents treatment recommendations, including dosage, products, guidelines for monitoring, and discontinuation. Advances in the neurobiology of anxiety are also included.
Yates
W R
WR
Department of Psychiatry, University of Iowa College of Medicine, Iowa City.
Wesner
R B
RB
D001008:Anxiety Disorders / Q000145:classification / Q000628:therapy*; D005081:Exercise Therapy; D006801:Humans; D009446:Neurobiology; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012064:Relaxation Therapy
D011619:Psychotropic Drugs